Effect of vitamin d status on pharmacological treatment efficiency impact on cost-effective management in medicine

Dermato-Endocrinology

Volumn 5, Issue 2, 2013, Pages 299-304

  Karczmarewicz, Elzbieta ^a   Czekuc Kryskiewicz, Edyta ^a   Pludowski, Pawel ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

25 hydroxyvitamin d; Atopic dermatitis; Chronic hepatitis c; Epilepsy; Multiple sclerosis; Osteoporosis; Tuberculosis; Vitamin d deficiency

Indexed keywords

25 HYDROXYVITAMIN D; INTERFERON; VITAMIN D;

ARTICLE; ATOPIC DERMATITIS; CHRONIC KIDNEY DISEASE; DRUG EFFICACY; EPILEPSY; HEPATITIS C; HUMAN; MULTIPLE SCLEROSIS; OSTEOPOROSIS; TUBERCULOSIS; VITAMIN D DEFICIENCY;

EID: 84885111935     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.25279     Document Type: Article

References (44)

1. Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik M, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009; 99:104-13; PMID:19268496; http://dx.doi. org/10.1016/j.pbiomolbio.2009.02.003
2. Charzewska J, Chlebna-Soko? D, Chybicka A, Czech-Kowalska J, Dobrzanska A, Helwich E, et al.; Zespo? Ekspertow. Prophylaxis of vitamin D deficiency-Polish recommendation 29. Ginekol Pol 2010; 81:149-53; PMID:20232716
3. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2
4. Am J Clin Nutr 2008; 88:1519-27; PMID:19064511; http://dx.doi.org/10. 3945/ ajcn.2008.26182 4. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988
5. Arch Intern Med 2009; 169:626-32; PMID:19307527; http://dx.doi. org/10.1001/archinternmed.2008.604
6. Chlebna-Soko? D, Golec J, Karalus J. Vitamin D supplementation in children and adolescents in Poland. Standardy Medyczne. Pediatria (Napoli) 2012; 9:701-4
7. Babinska E, Abramowicz P, Werpachowska I, et al. Potential associations between deficits of vitamin D and hypertension in adolescents: a pilot study. Standardy Medyczne. Pediatria (Napoli) 2012; 9:722
8. Walentowicz-Sad?ecka M, Grabiec M, Sad?ecki P, et al. Ocena stezen 25(OH)D3 u pacjentek z rakiem jajnika i ich zwiazek z piecioletnimi przezyciami. Standardy Medyczne. Pediatria (Napoli) 2012; 9:722
9. Karczmarewicz E, Kryskiewicz E, Skorupa E, et al. Ocena zaopatrzenia organizmu w witamine D w prezentowanej grupie dzieci polskich. Standardy Medyczne. Pediatria (Napoli) 2012; 9:727
10. Czech-Kowalska J, P?udowski P, Dobrzanska A, Kryskiewicz E, Karczmarewicz E, Gruszfeld D, et al. Impact of vitamin D supplementation on markers of bone mineral metabolism in term infants. Bone 2012; 51:781-6; PMID:22776138; http://dx.doi. org/10.1016/j.bone.2012.06.023
11. Czech-Kowalska J, P?udowski P, Dobrzanska A, et al. Wp?yw suplementacji witaminy D na stezenie 25-hydroksywitaminy D u noworodkow urodzonych o czasie. Standardy Medyczne. Pediatria (Napoli) 2012; 9:729
12. Czech-Kowalska J, Kryskiewicz E, Jaworski M, et al. Wp?yw pory roku na zasoby witaminy D oraz mase kostna u matek i ich potomstwa po urodzeniu -badanie wieloosrodkowe. Wyniki wstepne. Standardy Medyczne. Pediatria (Napoli) 2012; 9:730
13. Marc M, Socha P, Rusin J, et al. Determinanty poziomu 25(OH)D u dzieci dwu-trzyletnich zamieszkujacych region po?udniowo-wschodniej Polski. Standardy Medyczne. Pediatria (Napoli) 2012; 9:733
14. P?udowski P, Socha P, Karczmarewicz E, et al. Vitamin D supplementation and 25-hydroxyvitamin D in infants -a prospective cohort observational study. J Ped Gastroenterol Nutr. 2011; 93-99.
15. Pluta A, Karwacki A, Proszynska K, et al. Zasoby ustrojowe witaminy D matek i noworodkow w chwili urodzenia w zaleznosci od pory roku. Pol Tyg Lek (Wars) 1987; 42:254-6
16. Zmijewska MA, Kmiec P, Waszak PM, et al. Vitamin D deficiency in population of pomeranian region of Poland. Standardy Medyczne. Pediatria (Napoli) 2012; 9:735
17. Napiorkowska L, Budlewski T, Jakubas-Kwiatkowska W, Hamzy V, Gozdowski D, Franek E. Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland. Pol Arch Med Wewn 2009; 119:699-703; PMID:19920793
18. Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients. World J Gastroenterol 2011; 17:5184-90; PMID:22215943; http://dx.doi. org/10.3748/wjg.v17.i47.5184
19. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011; 24:43-50; PMID:20649944; http://dx.doi.org/10. 1111/j.1432-2277.2010.01141.x
20. Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naive patients. World J Gastroenterol 2012; 18:800-5; PMID:22371640; http://dx.doi.org/10.3748/wjg.v18.i8.800
21. Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, et al.; Swiss Hepatitis C Cohort Study Group. A genetic validation study reveals a role of vitamin D metabolism in the response to interferonalfa-based therapy of chronic hepatitis C. PLoS One 2012; 7:e40159; PMID:22808108; http://dx.doi. org/10.1371/journal.pone.0040159
22. Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sene D, et al. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 2012; 51:2083-90; PMID:22908327; http://dx.doi.org/10.1093/rheumatology/ kes209
23. Sato S, Tanino Y, Saito J, Nikaido T, Inokoshi Y, Fukuhara A, et al. The relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis. Respir Investig 2012; 50:40-5; PMID:22749249; http://dx.doi.org/10.1016/j. resinv.2012.05.002
24. Ganmaa D, Giovannucci E, Bloom BR, Fawzi W, Burr W, Batbaatar D, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, doubleblind, placebo-controlled feasibility trial. Am J Clin Nutr 2012; 96:391-6; PMID:22760564; http://dx.doi. org/10.3945/ajcn.112.034967
25. Leis KS, McNally JD, Montgomery MR, et al. Vitamin D intake in young children with acute lower respiratory infection. [Epub ahead of print]. Am J Clin Nutr 2012
26. Samochocki Z, Bogaczewicz J, Jeziorkowska R, Sysa-Jedrzejowska A, Glinska O, Karczmarewicz E, et al. Vitamin D effects in atopic dermatitis. J Am Acad Dermatol 2013; PMID:23643343; http://dx.doi. org/10.1016/j.jaad.2013.03.014
27. Pierrot-Deseilligny C, Rivaud-Pechoux S, Clerson P, de Paz R, Souberbielle JC. Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord 2012; 5:187-98; PMID:22783368; http://dx.doi.org/10.1177/ 1756285612447090
28. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 2012; 7:216-23; PMID:22266572; http:// dx.doi.org/10.2215/CJN.04760511
29. Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, et al. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2012; 96:672-9; PMID:22854402
30. Carmel AS, Shieh A, Bang H, Bockman RS. The 25(OH)D level needed to maintain a favorable bisphosphonate response is ? 33 ng/ml. Osteoporos Int 2012; 23:2479-87; PMID:22237813; http://dx.doi. org/10.1007/s00198-011-1868-7
31. Peris P, Martinez-Ferrer A, Monegal A, Martinez de Osaba MJ, Muxi A, Guanabens N. 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone 2012; 51:54-8; PMID:22487299; http://dx.doi. org/10.1016/j.bone.2012.03.026
32. Deane A, Constancio L, Fogelman I, Hampson G. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet Disord 2007; 8:3; PMID:17214897;. org/10.1186/1471-2474-8-3
33. Olmos JM, Hernandez JL, Llorka J, et al. Effects of 25-hydroxyvitamin D3 therapy on bone turnover markers and PTH levels in postmenopausal osteopororic woman treated with alendronate. J Clin Endocrinol Metab 2012; 97:12; jc.2012-2999
34. Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, et al. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 2010; 25:447-54; PMID:20200999;
35. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, et al. The impact of vitamin D status on periodontal surgery outcomes. J Dent Res 2011; 90:1007-12; PMID:21555774;. org/10.1177/0022034511407771
36. Hokugo A, Christensen R, Chung EM, Sung EC, Felsenfeld AL, Sayre JW, et al. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res 2010; 25:1337-49; PMID:20200938;. org/10.1002/jbmr.23
37. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, et al. Effect of highdosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010; 170:813-20; PMID:20458090;
38. Hogberg G, Gustafsson SA, Hallstrom T, Gustafsson T, Klawitter B, Petersson M. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. [Epub ahead of print]. Acta Paediatr 2012; 101:779-83; PMID:22372707; http://dx.doi.org/10.1111/j.1651- 2227.2012.02655.x
39. Huang W, Shah S, Long Q, Crankshaw AK, Tangpricha V. Improvement of Pain, Sleep, and Quality of Life in Chronic Pain Patients With Vitamin D Supplementation. Clin J Pain 2013; 29:341-7; PMID:22699141; http://dx.doi.org/ 10.1097/ AJP.0b013e318255655d
40. Khoraminya N, Tehrani-Doost M, Jazayeri S, Hosseini A, Djazayery A. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 2013; 47:271-5; PMID:23093054; http://dx.doi. org/10.1177/0004867412465022
41. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29:21-30; PMID:15589699; http://dx.doi. org/10.1016/j.jchemneu.2004.08.006
42. Christiansen C, Rodbro P, Sjo O. "Anticonvulsant action"of vitamin D in epileptic patients? A controlled pilot study. Br Med J 1974; 2:258-9; PMID:4207965; http://dx.doi.org/10.1136/bmj.2.5913.258
43. Hollo A, Clemens Z, Kamondi A, Lakatos P, Szucs A. Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav 2012; 24:131-3; PMID:22503468; http://dx.doi. org/10.1016/j.yebeh.2012.03.011
44. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30; PMID:21646368; http://dx.doi.org/10.1210/jc. 2011-0385